| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Acrivastine | Acrivastine Impurity 1 | VL790001 | View CAS 87848-99-5 |
| Acrivastine | Acrivastine Z Isomer | VE007795 | View CAS 1057138-89-2 |
Acrivastine Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Acrivastine | Acrivastine Impurity 1 | VL790001 | View CAS 87848-99-5 |
| Acrivastine | Acrivastine Z Isomer | VE007795 | View CAS 1057138-89-2 |
| Catalogue No. | VE007795 |
| CAS No. | 1057138-89-2 |
| Molecular Formula | C22H24N2O2 |
| Molecular Weight | 348.4 g/mol |
| Parent drug | Acrivastine |
| IUPAC Name | (E)-3-(6-((Z)-3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridin-2-yl)acrylic acid |
| Synonyms | N/A |
| References | Kumar, Ajay, et al. “Identification, Synthesis and Structural Characterization of Process Related and Degradation Impurities of Acrivastine and Validation of HPLC Method.” Journal of Pharmaceutical and Biomedical Analysis, vol. 133, Jan. 2017, pp. 15–26, https://doi.org/10.1016/j.jpba.2016.10.015. |
| Status | In-stock |
| ListName | Acrivastine Z Isomer |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
